Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Gretch

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Virology|April 1, 2006
Identification of a specific gene expression pattern associated with HCV-induced pathogenesis in HCV- and HCV/HIV-infected individualsKathie-Anne Walters, Maria W Smith, Sampa Pal, et al.
Gastroenterology|January 24, 2007
Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis CMitchell L Shiffman, Marc G Ghany, Timothy R Morgan, et al.
Hepatology (Baltimore, Md.)|February 24, 2005
Associations among clinical, immunological, and viral quasispecies measurements in advanced chronic hepatitis CAlan Lee Rothman, Chihiro Morishima, Herbert L Bonkovsky, et al.
Gastrointestinal Endoscopy|December 5, 2006
The prevalence and risk factors associated with esophageal varices in subjects with hepatitis C and advanced fibrosisArun J Sanyal, Robert J Fontana, Adrian M Di Bisceglie, et al.
Hepatology (Baltimore, Md.)|September 26, 2008
Interpretation of positive transcription-mediated amplification test results from polymerase chain reaction-negative samples obtained after treatment of chronic hepatitis CChihiro Morishima, Timothy R Morgan, James E Everhart, et al.
Hepatology (Baltimore, Md.)|July 28, 2006
HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trialChihiro Morishima, Timothy R Morgan, James E Everhart, et al.
Journal of Hepatology|September 2, 2005
Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C TrialAdrian M Di Bisceglie, Richard K Sterling, Raymond T Chung, et al.
Hepatology (Baltimore, Md.)|May 13, 2009
Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trialTania Mara Welzel, Timothy R Morgan, Herbert L Bonkovsky, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Virology|April 1, 2006
Identification of a specific gene expression pattern associated with HCV-induced pathogenesis in HCV- and HCV/HIV-infected individualsKathie-Anne Walters, Maria W Smith, Sampa Pal, et al.
Gastroenterology|January 24, 2007
Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis CMitchell L Shiffman, Marc G Ghany, Timothy R Morgan, et al.
Hepatology (Baltimore, Md.)|February 24, 2005
Associations among clinical, immunological, and viral quasispecies measurements in advanced chronic hepatitis CAlan Lee Rothman, Chihiro Morishima, Herbert L Bonkovsky, et al.
Gastrointestinal Endoscopy|December 5, 2006
The prevalence and risk factors associated with esophageal varices in subjects with hepatitis C and advanced fibrosisArun J Sanyal, Robert J Fontana, Adrian M Di Bisceglie, et al.
Hepatology (Baltimore, Md.)|September 26, 2008
Interpretation of positive transcription-mediated amplification test results from polymerase chain reaction-negative samples obtained after treatment of chronic hepatitis CChihiro Morishima, Timothy R Morgan, James E Everhart, et al.
Hepatology (Baltimore, Md.)|July 28, 2006
HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trialChihiro Morishima, Timothy R Morgan, James E Everhart, et al.
Journal of Hepatology|September 2, 2005
Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C TrialAdrian M Di Bisceglie, Richard K Sterling, Raymond T Chung, et al.
Hepatology (Baltimore, Md.)|May 13, 2009
Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trialTania Mara Welzel, Timothy R Morgan, Herbert L Bonkovsky, et al.
Pageof 5